ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 77 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $54,000 | -41.3% | 14,336 | +3.5% | 0.00% | – |
| Q3 2019 | $92,000 | -79.7% | 13,846 | -20.9% | 0.00% | – |
| Q2 2018 | $453,000 | +39.8% | 17,503 | +29.0% | 0.00% | – |
| Q1 2018 | $324,000 | -15.0% | 13,573 | +20.6% | 0.00% | – |
| Q4 2017 | $381,000 | +55.5% | 11,251 | -2.7% | 0.00% | – |
| Q3 2017 | $245,000 | +16.1% | 11,569 | -4.2% | 0.00% | – |
| Q2 2017 | $211,000 | -11.3% | 12,077 | -10.9% | 0.00% | – |
| Q1 2017 | $238,000 | +21.4% | 13,559 | +17.2% | 0.00% | – |
| Q4 2016 | $196,000 | -1.0% | 11,570 | -4.1% | 0.00% | – |
| Q3 2016 | $198,000 | -78.1% | 12,068 | -79.8% | 0.00% | -100.0% |
| Q2 2016 | $903,000 | +2.1% | 59,610 | -4.8% | 0.00% | 0.0% |
| Q1 2016 | $884,000 | -12.1% | 62,610 | +76.4% | 0.00% | 0.0% |
| Q4 2015 | $1,006,000 | +20.6% | 35,502 | -28.8% | 0.00% | 0.0% |
| Q3 2015 | $834,000 | -33.6% | 49,874 | +4.1% | 0.00% | 0.0% |
| Q2 2015 | $1,256,000 | +8871.4% | 47,921 | +6446.6% | 0.00% | – |
| Q3 2014 | $14,000 | – | 732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C Partners Holding GmbH | 1,662,128 | $29,037,000 | 9.28% |
| GREAT POINT PARTNERS LLC | 608,650 | $10,645,000 | 4.68% |
| Opaleye Management Inc. | 255,000 | $4,460,000 | 2.07% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 326,530 | $5,721,000 | 0.47% |
| Granite Point Capital Management, L.P. | 61,813 | $1,076,000 | 0.39% |
| WALL STREET ASSOCIATES | 225,000 | $3,935,000 | 0.37% |
| EMERALD ADVISERS, LLC | 322,631 | $5,652,000 | 0.28% |
| Spark Investment Management LLC | 75,500 | $1,317,000 | 0.18% |
| TFS CAPITAL LLC | 98,443 | $1,722,000 | 0.17% |
| PRIVATE ASSET MANAGEMENT INC | 47,690 | $834,000 | 0.14% |